What one share of CytoDyn holds
CytoDyn Inc. (together with its wholly owned subsidiary, the “Company”) was originally incorporated under the laws of Colorado on May 2, 2002, under the name RexRay Corporation and, effective August 27, 2015, reincorporated under the laws of Delaware.
CytoDyn’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-08-31; the balance sheet is as of 2026-08-31.
| Profit | −$0.04 |
|---|---|
| Cash and investments | $0.01 |
| Debt | $0.02 |
| Book value | −$0.07 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | — | −$0.18 | $0.00 | −$0.09 | — | −$0.22 |
| 2012 | — | −$0.31 | — | — | — | −$0.14 |
| 2013 | — | −$0.32 | $0.00 | −$0.11 | — | −$0.01 |
| 2014 | — | −$0.27 | $0.00 | −$0.16 | — | $0.07 |
| 2015 | — | −$0.43 | $0.00 | −$0.21 | — | −$0.17 |
| 2016 | — | −$0.27 | $0.00 | −$0.26 | — | $0.08 |
| 2017 | — | −$0.19 | $0.00 | −$0.19 | — | −$0.01 |
| 2018 | — | −$0.29 | $0.00 | −$0.17 | — | −$0.06 |
| 2019 | — | −$0.21 | $0.00 | −$0.19 | — | −$0.03 |
| 2020 | — | −$0.33 | $0.00 | −$0.16 | — | −$0.00 |
| 2021 | $0.00 | −$0.30 | $0.00 | −$0.20 | — | −$0.03 |
| 2022 | $0.00 | −$0.31 | — | — | — | −$0.13 |
| 2023 | $0.00 | −$0.10 | — | — | — | −$0.12 |
| 2024 | — | −$0.05 | — | — | — | −$0.11 |
| 2025 | — | $0.00 | — | — | — | −$0.08 |
| 2026 | — | −$0.03 | — | — | — | −$0.08 |
Common questions about CytoDyn
How much does one share of CytoDyn earn?
Over the last 12 months, CytoDyn lost $0.04 for each share.
Does CytoDyn pay a dividend?
CytoDyn didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is CytoDyn’s book value per share?
CytoDyn’s book value is negative (−$0.07 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of August 31, 2026.
How much cash and debt does each share of CytoDyn have?
Each share of CytoDyn has $0.01 of cash and investments and $0.02 of debt, as of August 31, 2026.
Has CytoDyn bought back shares?
CytoDyn’s share count rose about 6017% from 2011 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.